MAQC
Massive Analysis and Quality Control Society
2022 MAQC Society 5th Annual Meeting will occur on Sept 26-27
Location: FDA HQ, Silver Spring, MD.
Registration: Coming Soon
Announcing Nominations are Open for the 2022 MAQC Society Awards
The MAQC Society is accepting nominations for two awards:
- MAQC Society Award (for MAQC Society members with an important scientific article published in 2021)
- Outstanding Reproducibility in Science Award (open to all individuals with an important scientific article published in 2021)
Eligibility: Exclusions to the individuals mentioned above are the Executive Officers of the MAQC Society and the Chair of the MAQC Society Awards Committee. Regular MAQC Board members are eligible but cannot be nominated by other MAQC Board members.
Criteria for award: Awardee must have had a key role (first, corresponding, or primary author) of a significant published scientific article promoting, establishing, or contributing to reproducible science, especially of massive datasets in human health sciences. The awardee cannot nominate themselves. Upon receiving applications, the MAQC Society Awards Committee will review applications and decide on the winner in each category. The paper must have been peer-reviewed and published (electronically or otherwise) in the previous calendar year (2021).
Application process: Nominations are taken by filling out an online form
Application deadline: March 31, 2022
More details about the awards are found on our awards page.
Nature Biotechnology Special Collection
Publications in Collection
-
Salit, M. & Woodcock, J. MAQC and the era of genomic medicine. Nat. Biotechnol. 1–2 (2021).
-
Xiao, W. et al. Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nat. Biotechnol. 1–10 (2021).
-
Fang, L. T. et al. Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nat. Biotechnol. 1–10 (2021).
-
Chen, W. et al. A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples. Nat. Biotechnol. 1–12 (2020).
-
Deveson, I. W. et al. Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nat. Biotechnol. 1–14 (2021).
-
Foox, J. et al. Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study. Nat Biotechnol. 39, 1129–1140 (2021).
-
Chen, X. et al. A multi-center cross-platform single-cell RNA sequencing reference dataset. Sci. Data 8, 39 (2021).
-
Gong, B. et al. Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions. Genome Biol. 22, 109 (2021).
-
Jones, W. et al. A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency. Genome Biol. 22, 111 (2021).
-
Zhang, L. et al. X-CNV: genome-wide prediction of the pathogenicity of copy number variations. Genome Med. 13, 132 (2021).
